Author:
Shehata Fatma,Abdel Monem Nihad,Sakr Mohamed,Kasem Samar,Balbaa Mahmoud
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference37 articles.
1. Cheng A, Kang Y, Lin D, Park J, Kudo M, Qin S, Omata M, Pitman Lowenthal SW, Lanzalone S, Yang L, Lechuga M, Raymond E. Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC). J Clin Oncol. 2011;29:4000.
2. Andrade LJ, D’Oliveira A, Melo RC, De Souza EC, Silva CA, Parana R. Association between hepatitis C and hepatocellular carcinoma. J Global Infect Dis. 2009;1:33–7.
3. Van Malenstein H, Van Pelt J, Verslype C. Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer. 2011;47:1789–97.
4. Braicu C, Burz C, Berindan-Neagoe L, Balacescu O, Graur F, Cristea V, Irimie A. Hepatocellular carcinoma: tumorigenesis and prediction markers. Gastroenterol Res. 2009;2:191–9.
5. Rajkumar T. Growth factors and growth factor receptors in cancer. Curr Sci. 2001;81:535–41.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献